These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33393765)

  • 41. Bioactive Molecule Prediction Using Extreme Gradient Boosting.
    Babajide Mustapha I; Saeed F
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapacuronium and bronchospasm.
    Goudsouzian NG
    Anesthesiology; 2001 May; 94(5):727-8. PubMed ID: 11388519
    [No Abstract]   [Full Text] [Related]  

  • 43. Muscle toxicity with statins.
    Hedenmalm K; Alvan G; Ohagen P; Dahl ML
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors.
    Adeluwa T; McGregor BA; Guo K; Hur J
    Front Pharmacol; 2021; 12():648805. PubMed ID: 34483896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapacuronium redux.
    Schulman SR
    Anesth Analg; 2002 Mar; 94(3):483-4. PubMed ID: 11867361
    [No Abstract]   [Full Text] [Related]  

  • 46. Rapacuronium administration to two children with Duchenne's muscular dystrophy.
    Frankowski GA; Johnson JO; Tobias JD
    Anesth Analg; 2000 Jul; 91(1):27-8. PubMed ID: 10866881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the intubation conditions provided by rapacuronium (ORG 9487) or succinylcholine in humans during anesthesia with fentanyl and propofol.
    Fleming NW; Chung F; Glass PS; Kitts JB; Kirkegaard-Nielsen H; Gronert GA; Chan V; Gan TJ; Cicutti N; Caldwell JE
    Anesthesiology; 1999 Nov; 91(5):1311-7. PubMed ID: 10551582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Current movements of four serious adverse events induced by medicinal drugs based on spontaneous reports in Japan].
    Sudo C; Azuma Y; Maekawa K; Kaniwa N; Sai K; Saito Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):111-7. PubMed ID: 22259851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rhabdomyolysis risk from the use of two-drug combination of antidyslipidemic drugs with antihypertensive and antidiabetic medications: a signal detection analysis.
    Gosho M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):339-346. PubMed ID: 30575126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
    Wei Y; Li W; Du T; Hong Z; Lin J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapacuronium: why did it fail as a replacement for succinylcholine?
    White PF
    Br J Anaesth; 2002 Feb; 88(2):163-5. PubMed ID: 11878650
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.
    Larijani GE; Zafeiridis A; Goldberg ME
    Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapacuronium and the risk of bronchospasm in pediatric patients.
    Rajchert DM; Pasquariello CA; Watcha MF; Schreiner MS
    Anesth Analg; 2002 Mar; 94(3):488-93; table of contents. PubMed ID: 11867363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Another possible mechanism for bronchospasm after rapacuronium.
    Stuth EA; Stucke AG; Setlock MA
    Anesthesiology; 2002 Jun; 96(6):1528-9. PubMed ID: 12170075
    [No Abstract]   [Full Text] [Related]  

  • 58. ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning.
    Jiang D; Lei T; Wang Z; Shen C; Cao D; Hou T
    J Cheminform; 2020 Mar; 12(1):16. PubMed ID: 33430990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis.
    Jiang W; Wang X; Zhou S
    Expert Opin Drug Saf; 2016; 15(3):357-65. PubMed ID: 26750987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinico-pharmacologic explanation models of cerivastatin associated rhabdomyolysis].
    Zeitlinger M; Müller M
    Wien Med Wochenschr; 2003; 153(11-12):250-4. PubMed ID: 12879633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.